Pacibekitug safely reduces inflammatory biomarkers in kidney disease patients

https://www.news-medical.net/news/20260829/Pacibekitug-safely-reduces-inflammatory-biomarkers-in-kidney-disease-patients.aspx The interleukin-6 (IL-6) antibody, pacibekitug, produced sustained reductions in inflammatory biomarkers in patients with chronic kidney disease at high inflammatory risk, according to results from the phase II TRANQUILITY trial presented in a Hot Line session today at ESC Congress 2026.

Researchers identify early molecular warning signs of inflammatory bowel disease

https://www.news-medical.net/news/20260829/Researchers-identify-early-molecular-warning-signs-of-inflammatory-bowel-disease.aspx Researchers have uncovered early molecular warning signs of inflammatory bowel disease, revealing the condition can begin before symptoms appear and continue silently even when patients appear well.

HRT linked to lower dementia risk, but timing and menopause type matter

https://www.news-medical.net/news/20260827/HRT-linked-to-lower-dementia-risk-but-timing-and-menopause-type-matter.aspx A large UK Biobank analysis reveals how menopause type, estrogen exposure, genetics, and the timing of HRT may shape its relationship with dementia risk.

Switch to once-weekly, single-tablet islatravir–lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial

Switch to once-weekly, single-tablet islatravir–lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial Dr Amy E Colson, MDa,b Send email to acolson@challiance.org ∙ Princy N Kumar, MDc ∙ Peter J Ruane, MDd ∙ Ploenchan Chetchotisakd, MDe ∙ Winai Ratanasuwan, MDf ∙ Afaaf Liberty, MBChBg ∙ et al. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01442-X/abstract?dgcid=raven_jbs_etoc_feature_lancet

Pre-eclampsia Prof Mark C Walker, MDa,b,c,d Send email to mwalker@toh.ca ∙ Malia S Q Murphy, PhDb ∙ Sara C Scremin Souza, MScb ∙ Koiwah Koi-Larbi, LLMe ∙ Maria Laura Costa, MDf ∙ Prof Jon Hyett, MDg,h ∙ et al.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01071-8/abstract?dgcid=raven_jbs_etoc_feature_lancet

Biosecurity in a rapidly changing world The Lancet +...

Biosecurity in a rapidly changing world The Lancet https://www.thelancet.com/journals/lancet/issue/vol408no10557/PIIS0140-6736(26)X2032-3

Access to Care Community of Practice Event: Speaker Update September 9th from 1 - 2 PM CT / 12 - 1 PM MT!

https://events.gcc.teams.microsoft.com/event/0ffaa37c-4302-44c3-9628-2aeffc28c594@d58addea-5053-4a80-8499-ba4d944910df?source=copyLinkLegacyShareLinkDialog&utm_medium=email&utm_source=govdelivery Access to Care Community of Practice Event: Speaker Update The Region 6 Office of the Assistant Secretary for Health (OASH) is excited to announce the launch of the Access to Care Community of Practice! This is a free event and is open to all partners interested in joining and participating in this new regional peer-to-peer learning initiative. Future meetings will be held on a quarterly basis and will feature innovations in care delivery in rural or low-access settings. Please join us for the inaugural session on September 9th from 1 - 2 PM CT / 12 - 1 PM MT! During the September 9th event, Sarah Hohman, the Director of Government Affairs at the National Association of Rural Health Clinics (NARHC), will present on the rural health landscape, including key challenges impacting access to quality health care in rural, medically underserved communities, such as clinic and hospital financial instability, workforce shortages, maternity care access, behavioral health, and chronic disease. This presentation will also showcase federal programs and funding opportunities, technical assistance and other resources, policy efforts, and partnerships designed to improve access to care and support rural hospitals and clinics.